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Non-chelating bidentate ligands 1,4- and 1,3-
bis(imidazol-l-yl-methylene)benzenes 5 and 6 and 1,3-
and 1,4-bis (benzimidazol-I-yl-methylene) benzenes 7
and 8 have been prepared by treating 1,3- and 1,4-
xylene dibrornides with imidazole and benzimidazole
respectively. The compounds have been characterized
by spectral (IH NMR, I C NMR and MS) data.
The supramolecular chemistry has led to the
development of various facets of chemistry,
biochemistry, medicinal chemistry and physics. In
more recent years a new approach involving self-
assembly of non-chelating ligands around the
metal ions has been developed due to their ease in
synthesis and higher yields over their organic
counterparts. Though such molecules have shown
significant degree of substrate specificity, the slow
progress of this facet of supramolecular chemistry
is mainly plagued by the non-availability of
appropriately designed non-chelating bidentate
ligands. The literature reported ligands are
invariably based upon pyridine units \,2. The
imidazolelbenzimidazole has significant role in
biochemical reactions. Herein we present a simple
approach for the synthesis of
imidazolelbenzimidazole based non-chelating











The suspension of imidazole (2.2 mole), 1,4-
xylene dibromide (1.0 mole) and potassium-t-
butoxide in dry ether containing 18-crown-6 (as
catalyst) on stirring at room temperature gave 1,4-
bis(imidazol-I-yl-methylene )benzene 5 in 60%
yield, m.p. 74° (lit. m.p. 65-75oC)3, m/z 238 (M+).
The structure of this compound could be assigned
on the basis of the presence of one CH2 signal at 8
5.10 (the corresponding signal is at 8 4.43 in xylene
dibromide), alon?3 with imidazole and phenyle~e
signals. Further C NMR also corroborates this
structure. In this reaction, on using two equivalents
of imidazole, imidazole-l-yl-xylene bromide [m/z
250 and 252 (M+)] remained as an impurity and
could not be purified. Use of KF, KF-K2C03 and
K2C03 as bases and tetrabutyl ammonium hydrogen
sulphate as catalyst always led to a mixture of
products. So the use of 10% excess of imidazole
over the stoichiometric amount of dibromide and
potassium-t-butoxide and 18-crown-6 as catalyst
constitute optimum conditions for the synthesis.
Similarly, reaction of 1,3-xylene dibromide with
imidazole yielded 1,3-bis(imidazol-l-yl-
methylene)benzene 6 in 60% yield, m.p. 62°C, m/z
238 (M+).
1,3- and 1,4-bis(benzimidazole-l-yl-methylene)
benzenes were prepared under analogous conditions
using dry CH3CN as a solvent. 7 was obtained in
70% yield, m.p. 109°C, mJz 338 (M+) and also 8 in
70% yield, m.p. 124°C, m/z 338 (M+).
Experimental Section
m- And p-xylenes, benzoyl perossde and N-
bromosuccinimide were procured from Loba,





purchased from G~tlXO, Bombay. m- and p-xylene
dibromides were prepared by the reported methods' .
'n and DC NMR spectra of the ligands were
recorded on Bruker A.c. 200 MHz instrument using
TMS as an internal reference. The +ve, -ve and
absent signal pertain to the nature of signal in DEPT
spectrum relative to normal 13C spectrum. Mass
spectra of compounds were recorded on Shimadzu
GeMS OP 2000 A.
1,4-Bis(imidazol-l-yl-methylene) benzene 5.
1,4-Xylene dibromide (4 g; 0.015 mol) was rapidly
added to the reaction mixture containing imidazole
(2.18 g; 0.032 mole), potasium-t-butoxide (3.57 g;
0.032 mole) and 18-crown-6 (3-4 mg as catalyst) in
dry acetonitrile. The contents were stirred for 20 h,
(TLC monitored) at 25±5°C. The reaction mixture
was filtered and the residue was washed twice with
acetonirile. The combined filtrate was concentrated
to dryness, extracted with CHCl3 and treated with
saline water to remove any base. The chloroform
layer was dried over anhyd. Na2S04' which on
concentration yielded crude product of the
compound which was recrystallised from CHClr
CH30H (1:1), yield 60%, m.p. 74°C; MS: mlz 238
(72.9, M+), 171 (86.9, M'<imidazole), 104 (100,
M+-2 imidazole). 'n NMR (CDCI): 0 7.54 (s, 2H, -
N=), 7.09 (dd, 4H), 7.16 (m, 4H) and 5.10 (s, 4H);
DC NMR (CDCI): 50.2 (CH2), 119.1 (CH), 127.7
(CH), 129.9 (CH), 136.4 (C), 137.2 (CH).
1,3-Bis(imidazol-l-yl-methylene)benzene 6. It
was prepared by the analogous method, yield 60%,
m.p. 62°C; MS: mlz 238 (55.7, M+), 171 (55.6, M+
-rmidazole), 104 (67.9, M+-2 imidazole), 91 (71.2.
tropolium ion), 68 (100, imidazole); 'n ~
(CDCI): 0 7.53 (s, 2H, -N=C-H), 7.08 (dd, 4H),
(
I)7.26 m, 4H) and 5.10 (s, 4H); C NMR (CDCI):
50.44 (-ve, CH2), 119.2 (+ve, CH), 125.91 (+ve,
CH), 127.12 (+ve, CH), 129.79 (+ve, CH), 130.07
(+ve, CH), 136.40 (ab, C), 137.38(+ve, CH).
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potassium-t-butoxide (3.57; 0.032 mol) and the
catalyst 18-crown-6 (3-4 mg) was stirred in dry
ether for 15 min and then m-xylene dibromide (4 g;
0.015 mole) quickly added. The contents were
stirred for 24 h (TLC monitored) and then filtered.
The residue was washed twice with ether and
refluxed with acetonitrile (50 mL) for I h to extract
the product. It was then filtered and residue washed
with two portions of acetonitrile (10 mL). The
combined filtrate was concentrated to half its
volume which on cooling gave crystals of product. It
was further purified by recrystallisation from
acetonitrile, yield 70%, m.p. 109°C; MS: mlz 338
(89.1,M+),221 (76.9, M'<benzimidazole), 104 (l00,
M'<benzimidazole), 91 (72.5, tropolium ion); 'n
NMR (CDCI), DMSO-d6): 7.28-7.13 (m lOH, ar-H),
8.16 (s, 2H, N=C-H)a, 7.69 (dd, 2H, J1=6 Hz, J2=2
Hz, peri-ar-H), 5.41 (s, 4H); IJC NMR (CDCI),
DMSO-d6): 47.20 (-ve, CH2), 114.01 (+ve, CH),
118.63 (+ve, CH), 120.63 (+ve, CH), 121.46 (+ve,
CH), 124.71 (+ve, CH), 125.40 (+ve, CH), 128.12
(+ve, CH), 132.47 (ab, C), 135.73 (ab, C), 142.29
(ab, C), 142.50 (+ve, CH).
1,4-Bis(benzimidazol-l-yl-methylene) benzene
8. It was prepared by the analogous method, yield
70%, m.p. 124°C; MS: mlz 338 (70.5, M+), 221
(100, M's-benzimidazoie), 104 (78.9, M+-2-
benzimidazole) and 91 (53.3, tropolium ion); 'H
NMR (CDC1),DMSO-d6): 7.40-7.19 (m 10H, ar-H),
7.79-7.59 (m, 2H), 8.49-7.90 (m, 2H), and 5.42 (s,
4H); J3C NMR (CDC1), DMSO-d6): 45.78 (-ve,
CH2), 113.58 (+ve, CH), 117.72 (+ve, CH), 120.33
(+ve, CH), 120.95 (+ve, CH), 127.19 (+ve, CH),
135.90 (ab, C), 141.50 (+ve, CH), 142.28 (ab, C).
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